Skip to main content

Gabriela Urcuyo Delgado

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Gabriela Urcuyo Delgado

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Juan Martin Dupraz

Juan Martin Dupraz

Gestió i Administració
Business Development Unit
Directorate of Innovation and Business Development
Read more
Arnau Noguera Segura

Arnau Noguera Segura

Predoctoral researcher
Microbiome Research
Read more
Andres Francisco Pacheco Reyes

Andres Francisco Pacheco Reyes

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
René Yeltsin Carvajal Junco

René Yeltsin Carvajal Junco

Predoctoral researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.